BRITTANY CABRERA: Open Payments
NPI 1801168976 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 52 payments from 13 companies in 2025. Trend: 2023 $835 · 2024 $807 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $186 |
| ABBVIE INC. | 10 | $176 |
| PFIZER INC. | 8 | $151 |
| Novo Nordisk Inc | 10 | $149 |
| Antares Pharma, Inc. | 3 | $56 |
| Aimmune Therapeutics, Inc. | 2 | $51 |
| Lilly USA, LLC | 3 | $47 |
| Exact Sciences Corporation | 2 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: AIRSUPRA, LINZESS, NURTEC ODT, Wegovy, Ozempic, PREVNAR 20, XYOSTED, ZENPEP.
Industry payments across OK — which companies pay providers there.
